Therefore, in this study including 376 RA patients and 463 controls, we investigated the possible association of polymorphisms in immune response genes (TNFA, IL1B, IL4, IL6, IL8, IL10, C1INH, TLR2, TLR4) and genes involved in tissue repair and apoptosis (PAI1, 5NOS2a, PARP) in relation to RA susceptibility, and with the use of anti-TNF-α therapy as selected marker of disease severity. The gene discussed is TLR2; the disease is rheumatoid arthritis.